This article proposes i) an economic framework to determine whether and in what circumstances price signalling is likely to have anticompetitive effects, and ii) some thoughts on a desirable standard to be adopted by the Commission in such cases. To read more, click the link below.
A tale of two stakeholder groups in regulating healthcare AI
Despite significant spending on healthcare in the US, the industry is slow to adopt AI technology that can cut costs and improve efficiency. In this CPI...